LUMEBLUE
LIVE

Serial Number

88064101

Owner

Cosmo Technologies Ltd

Attorney

John Pickerill

Filing Date

Aug 3, 2018

Add to watchlist:

No watchlists yet
View on USPTO

LUMEBLUE Trademark

Serial Number: 88064101 • Registration: 5952824

LUMEBLUE is a trademark filed by Cosmo Technologies Ltd on August 3, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Cosmo Technologies Ltd (23 trademarks)

Riverside II
Dublin 2 , IE

Entity Type: 99

Trademark Details

Filing Date

August 3, 2018

Registration Date

January 7, 2020

Published for Opposition

October 22, 2019

Goods & Services

Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing colonoscopy; Diagnostic agents, preparations and substances for medical purposes, namely, the visualization of colonic polyps, adenomas, carcinomas, early stage cancers and other lesions in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), those with previous history of polyps, adenomas, carcinomas, early stage cancers and other lesions, patients with colorectal cancer and patients with relevant family history; Diagnostic reagents and coloring agent for medical and surgical use; Coloring agent for use with imaging medical equipment; Coloring agent for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and polyps, adenomas, carcinomas, early stage cancers and other lesions thereon; pharmaceutical preparations for use in endoscopic or colonoscopic diagnostic evaluation; pharmaceutical preparations for enhancing visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions during gastrointestinal endoscopic procedures; pharmaceutical preparations for use in gastroenterology for colon and digestive system health and regulation; pharmaceutical preparations for use in endoscopy of the gastrointestinal tract; pharmaceutical preparations and preparations aiding detection, diagnosis, prevention and treatment related to the gastrointestinal field; pharmaceutical preparations and preparations aiding detection, diagnosis, prevention and treatment related to the gastrointestinal endoscopy field; pharmaceutical preparations to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; pharmaceutical preparations, namely, coloring agent for use in endoscopic procedures; pharmaceutical compositions, namely, coloring agent for use in endoscopy; pharmaceutical preparations for use as reagents for medical use; pharmaceutical preparations, namely, coloring agent for use in endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue for enhancing visualization during endoscopic procedures; pharmaceutical preparations containing dyes for enhancing visualization during endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue coloring agent for pharmaceutical, medical and surgical purposes; pharmaceutical preparations containing coloring agent dye for pharmaceutical, medical and surgical purposes; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes

Medical devices for use in endoscopic procedures of the gastrointestinal tract; Medical devices to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; Medical instruments to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; Medical devices for enhancing visualization during endoscopic procedures; Medical devices for enhancing visualization during endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; Medical devices for introducing compositions containing methylene blue into the human body for pharmaceutical, medical, surgical and medical diagnostic purposes; Medical devices for introducing compositions containing dye into the human body for pharmaceutical, medical, surgical and medical diagnostic purposes; Medical devices made with methylene blue for enhancing visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions for pharmaceutical, medical, surgical and medical diagnostic purposes; Medical devices made with dye for enhancing visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions for pharmaceutical, medical, surgical and medical diagnostic purposes; Medical devices for use in endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; Medical devices for use in endoscopy of the gastrointestinal tract

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 7, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 22, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 17, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 4, 2019 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 7, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 7, 2019 GNSL
SUSPENSION LETTER WRITTEN
Jun 7, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2019 CRFA
ASSIGNED TO LIE
Jun 3, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 28, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 27, 2018 GNRN
NON-FINAL ACTION E-MAILED
Nov 27, 2018 GNRT
NON-FINAL ACTION WRITTEN
Nov 27, 2018 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 10, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 9, 2018 NWOS
NEW APPLICATION ENTERED
Aug 7, 2018 NWAP